| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLX | Common Stock | +Grant/Award | $13,014 | +85 | +11.85% | $153.11 | 802 | Mar 28, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLX | Deferred Stock Units | +Grant/Award | $0 | +25 | +0.78% | $0.00 | 3,229 | Feb 9, 2024 | Common Stock | 25 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Receipt of Common Stock in lieu of portion of quarterly director's fee. |
| F2 | 1-for-1 |
| F3 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
| F4 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |